General Information of DTT (ID: TTQ38E9)

DTT Name Sodium/potassium-transporting ATPase (SPT ATPase) DTT Info
Gene Name ATP1A1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
3 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Digitoxin DMWVIGP Arrhythmia BC9Z Approved [1]
Digoxin DMQCTIH Arrhythmia BC9Z Approved [2]
Sanguinarine DMDINFS Dental plaque DA08.4 Approved [3]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PBI-05204 DM05WIU Pancreatic cancer 2C10 Phase 2 [4]
Rostafuroxin DMKQXDB Hypertension BA00-BA04 Phase 2 [5]
RX108 DM4XETK Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
------------------------------------------------------------------------------------
2 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Istaroxime DMWN09H Cardiac disease BA00-BE2Z Discontinued in Phase 2 [7]
Cordil DMQESM7 Heart arrhythmia BC65 Terminated [8]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Treatment of congestive heart failure--current status of use of digitoxin. Eur J Clin Invest. 2001;31 Suppl 2:10-7.
2 Fab antibody fragments: some applications in clinical toxicology. Drug Saf. 2004;27(14):1115-33.
3 Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-81.
4 First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf- beta and p70s6k, in patients with advanced solid tumors. Invest New Drugs. 2014 Dec;32(6):1204-12.
5 Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R529-35.
6 ClinicalTrials.gov (NCT03646071) A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.
7 Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship. J Med Chem. 2008 Aug 14;51(15):4601-8.
8 WO patent application no. 1995,0085,58, Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds.